ClinicalTrials.gov
public full text
Public Domain
Dronabinol Naltrexone Treatment for Opioid Dependence
The goal of this two-year study is to test the efficacy of dronabinol as an adjunct to maintenance treatment with naltrexone in opioid-dependent individuals. We hypothesize that administering dronabinol during detoxification and during the first few weeks of naltrexone treatment will lead to improved naltrexone tolerability, resulting in better naltrexone compliance and treatment retention, and ultimately a reduction in opioid use and relapse rates.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dronabinol Treatment for Marijuana Addiction#1032832
- Dronabinol for Agitation in Dementia Crossover Trial#1183307
- Effects of Dronabinol (Oral THC) on Cannabis Use#1281290
- Community Opioid Overdose Prevention and Naloxone Distribution Programs: An Evidence-to-Practice Review#365484
- Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study#813994
Record · ID 1228107
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive